Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.
Investor's Business Daily on MSN
Stock Market Today: Nasdaq, S&P End Sharply Lower With Meta's Plunge
Meta stock plunged more than 9% after the Facebook parent company reported third-quarter results. A strong performance from ...
Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the ...
Investor's Business Daily on MSN
Dow Jones Stock Merck Tops Expectations, But Gardasil Challenges Remain
Dow Jones stock Merck topped third-quarter forecasts on Thursday, but shares skidded as its challenges with vaccine Gardasil continued.
Merck's Q3 2025 results saw huge growth in Winrevair and Capvaxive sales. Check out why I maintain my Strong Buy rating on ...
Merck reported Q3 2025 revenue of $17.3 billion and adjusted EPS of $2.58, both above expectations, and raised its full-year ...
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access . * Reflecting concerns, ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...
That's the situation with the following three undervalued healthcare stocks. So far this year, shares in dialysis center ...
The Fed’s next move comes amid increasing fears of weakness in the labor market; lower borrowing costs could help spur business activity and create more jobs. However, the rate cut decision arrives as ...
Bristol Myers Squibb has a 5.6% yield and has been building its drug pipeline with acquisitions. Merck has a 3.7% yield and a ...
Discover Merck & Co., Inc.'s Q3 earnings outlook as Keytruda's patent nears expiry. Click for my updated look at MRK stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results